| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | SVP Chief Commercial Officer | Chief Commercial Officer
1 company
Edwards Larry Todd is a See Remarks at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 7 sells.
Estimated insider holdings value: $4.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 29,131 | $25.16 | $732,927.22 | -16.2% | +3.9% | - | |
| Oct 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 4,504 | $20.04 | $90,263.31 | -1.2% | +36.7% | - | |
| May 19, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 7,451 | $14.07 | $104,849.73 | -3.9% | +14.3% | +33.2% | |
| Feb 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 2,173 | $12.70 | $27,597.10 | -1.6% | +21.4% | +106.4% | |
| Nov 30, 2024 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Buy | 1,093 | $7.11 | $7,766.86 | +0.8% | +5.0% | +132.9% | |
| Oct 2, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SVP Chief Commercial Officer | Sell | 3,725 | $10.01 | $37,295.45 | -2.7% | +36.2% | +107.7% | |
| May 17, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SVP Chief Commercial Officer | Sell | 7,640 | $8.98 | $68,581.99 | -5.2% | -7.6% | +53.4% |